Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Traumatic Brain Injury (tbi) Patients Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

4 recruiting trials for Traumatic Brain Injury (tbi) Patients. Eligibility criteria explained in plain English.

TrialFinderData lists 4 Traumatic Brain Injury (tbi) Patients clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Phase 3 is the largest group at 50% (1 studies); the largest phase groups are Phase 3: 1, Phase 2: 1.

Research is led by University of Louisville (1), Lagos State University (1), MetroHealth Medical Center (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Normal Saline (0.9% NaCl) (drug, 1 trial), followed by balanced crystalloid, Vitamin D3 (Cholecalciferol).

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
4
Total Trials
4
Recruiting Now
1
Phase 3 Trials
4
Sponsors

Track Traumatic Brain Injury (tbi) Patients trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGPhase 3NCT06953674

Saline Versus Balanced Crystalloid in Traumatic Brain Injury

The goal of this clinical trial is to determine which crystalloid (saline or balanced) should be used in the critical management of Traumatic Brain Injury (TBI) in moderate or...

Sponsor: University of LouisvilleEnrolling: 6001 location
RECRUITINGPhase 2NCT07269457

Vitamin D3 for Moderate to Mild Traumatic Brain Injury: A Randomized Trial on Inflammation and Recovery (VIMOT)

This study is a Phase II, randomized, quadruple-blinded, placebo-controlled clinical trial designed to test whether vitamin D₃ supplementation can improve recovery after...

Sponsor: Lagos State UniversityEnrolling: 2401 location
RECRUITINGNCT06734026

Multimodal, Enriched Environment for Rehabilitation in Chronic Traumatic Brain Injury

The goal of this study is to learn if a enhanced environment (Metro Café) with multi model approach (an approach that combines several therapies) in chronic traumatic brain injury...

Sponsor: MetroHealth Medical CenterEnrolling: 201 location
RECRUITINGNCT06899711

External Post-Operative Skull Prosthesis to Prevent Sunken Flap Syndrome in Craniectomy Patients

Patients that undergo decompressive craniectomy are at risk of delayed changes in brain function known as "Sunken Flap Syndrome" or "Syndrome of the Trephined." The goal of this...

Sponsor: Johns Hopkins UniversityEnrolling: 722 locations

Frequently Asked Questions

There are currently 4 clinical trials for Traumatic Brain Injury (tbi) Patients, with 4 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Traumatic Brain Injury (tbi) Patients, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 1 Phase 3 trials for Traumatic Brain Injury (tbi) Patients, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.